Fundraising Fox
Ampersand Biomedicines
3 known investors
Find your way into Ampersand Biomedicines
Sign up to see every warm intro you have to Ampersand Biomedicines
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ampersand Biomedicines team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ampersand develops a drug-design platform that localizes therapeutics to specific disease sites by separating molecular specificity from biological effect, producing "AND-Body" medicines across formats such as proteins, small molecules, LNPs, and nucleic acids. The company applies computational modeling, multi-omics mapping, and high-throughput binder generation to identify and engineer targets for next-generation therapeutics.
Founders & leadership
Investors · 3
How we know: Flagship Pioneering's portfolio page · the company's own site · a partner's Signal profile · funding news · globenewswire.com · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements$65M disclosed across 1 round · 2025
- $65MSeries BMar 2025 · 4 sources
Eli Lilly & Company, Eli Lilly and Company, Flagship Pioneering
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Ampersand Biomedicines went on to found or lead other companies.
In the news
Frequently asked questions
- What does Ampersand Biomedicines do?
- Ampersand develops a drug-design platform that localizes therapeutics to specific disease sites by separating molecular specificity from biological effect, producing "AND-Body" medicines across formats such as proteins, small molecules, LNPs, and nucleic acids. The company applies computational modeling, multi-omics mapping, and high-throughput binder generation to identify and engineer targets for next-generation therapeutics.
- Who are Ampersand Biomedicines's investors?
- Ampersand Biomedicines's investors include Flagship Pioneering.
- How much funding has Ampersand Biomedicines raised?
- Ampersand Biomedicines has disclosed $65M raised across 1 round.